James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,091
- Value
- $525.5K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,091 | $525.5K | <0.1% | +10.0% | Added | Holders |
| Q1 2026 | 2,090 | $454.5K | <0.1% | +435+26.3% | Added | Holders |
| Q4 2025 | 1,655 | $378.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,655 | $383.1K | <0.1% | −95−5.4% | Reduced | Holders |
| Q2 2025 | 1,750 | $324.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,750 | $366.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,750 | $311.1K | <0.1% | −235−11.8% | Reduced | Holders |
| Q3 2024 | 1,985 | $391.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,985 | $340.1K | <0.1% | −79−3.8% | Reduced | Holders |
| Q1 2024 | 2,064 | $375.4K | <0.1% | +79+4.0% | Added | Holders |
| Q4 2023 | 1,985 | $307.7K | <0.1% | −170−7.9% | Reduced | Holders |
| Q3 2023 | 2,155 | $321.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,155 | $290.2K | <0.1% | +391+22.2% | Added | Holders |
| Q1 2023 | 1,764 | $281.1K | <0.1% | +4+0.2% | Added | Holders |
| Q4 2022 | 1,760 | $284.5K | <0.1% | −40−2.2% | Reduced | Holders |
| Q3 2022 | 1,800 | $241.0K | <0.1% | −30−1.6% | Reduced | Holders |
| Q2 2022 | 1,830 | $281.0K | <0.1% | −110−5.7% | Reduced | Holders |
| Q1 2022 | 1,940 | $315.0K | <0.1% | +350+22.0% | Added | Holders |
| Q4 2021 | 1,590 | $216.0K | <0.1% | +1,590 | New | Holders |